Here we have defined the exact breakpoints of six previously identified deletion alleles disrupting the CYP2C19, CDH19, CASP3, DCLRE1C, DAB2IP and ITGA9 genes, respectively, and evaluated their association with breast cancer risk and disease subtype using a Northern Finnish case–control cohort. The gene discussed is CYP2C19; the disease is breast carcinoma.